Companydirectory

700,000 people experience heart attack symptoms annually, and will experience the agony of a long wait for test results. Capillary Film Technology (CFT) has developed affordable microfluidic testin...

• Funding £1,096,610
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Kent Surrey Sussex AHSN
• Status Clinical Trials

• Cardiovascular
• In-vitro Diagnostics

• Funding £1,043,720
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Imperial College Health Partners AHSN
• Status On Market

• Cancer
• Medical Devices

Tika is developing innovative reagents for improving rapid diagnosis of mycobacterial infections. Tika has discovered and optimised the use of a new supplement that in a laboratory setting can sign...

• Funding £1,089,480
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN South London AHSN
• Status On Market

• Biotechnology

TwistDX has developed a 15-minute point of care test for Chlamydia/Gonorrhoea. This enables diagnosis and treatment within one clinic visit, bringing significant clinical advantages of increased tr...

• Funding £99,928
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Eastern AHSN
• Status In Development

• In-vitro Diagnostics

UCL is developing an innovative application of cloud-based technology – Joint Dementia Research is intended to make it easier for people interested in taking part in dementia research to be conne...

• Funding £1,099,449
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Imperial College Health Partners AHSN
• Status In Development

• Neurological Conditions
• Digital/ICT/Mobile Solutions

The University of Edinburgh is developing a novel laboratory-based triage test to reduce the number of women with Human Papilloma Virus (HPV) infection referred for unnecessary colposcopy.

• Funding £98,336
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Please Select
• Status In Development

• In-vitro Diagnostics